Literature DB >> 12149240

Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity.

Marc Schmitz1, Senming Zhao, Knut Schäkel, Martin Bornhäuser, Detlef Ockert, Ernst Peter Rieber.   

Abstract

Functional studies on native human dendritic cells (DCs) are hampered by technical difficulties in preparing fresh DCs. Recently, with the help of the monoclonal antibody M-DC8, we succeeded in isolating a major subpopulation of human blood DCs by a one-step immunomagnetic separation procedure. These cells strongly express Fc gamma RIII (CD16) and Fc gamma RII (CD32) and are quite efficient in the antigen-specific activation of naive T cells. Because some Fc gamma receptor-bearing cell types are known as effector cells in antibody-dependent cellular cytotoxicity (ADCC), we investigated whether M-DC8(+) DCs are capable of effectuating ADCC. In this report we show that freshly prepared M-DC8(+) DCs efficiently mediate tumor-directed ADCC and that both types of Fc gamma receptors as well as tumor necrosis factor alpha essentially contribute to the cytotoxic activity. The results provide evidence that, in addition to their pivotal role in primary T-cell activation, a subset of blood DCs displays efficient cytotoxicity in ADCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149240

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Histamine H(4) receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity.

Authors:  Maria Gschwandtner; Knut Schäkel; Thomas Werfel; Ralf Gutzmer
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

2.  Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.

Authors:  Vincent Holl; Maryse Peressin; Sylvie Schmidt; Thomas Decoville; Susan Zolla-Pazner; Anne-Marie Aubertin; Christiane Moog
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

3.  Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Authors:  E Mimiola; O Marini; O Perbellini; A Micheletti; W Vermi; S Lonardi; C Costantini; E Meneghelli; A Andreini; C Bonetto; A Vassanelli; M Cantini; E Zoratti; D Massi; A Zamo'; A Leso; G Quaresmini; F Benedetti; G Pizzolo; M A Cassatella; C Tecchio
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

4.  Cytotoxic dendritic cells generated from cancer patients.

Authors:  Daniela Lakomy; Nona Janikashvili; Jennifer Fraszczak; Malika Trad; Sylvain Audia; Maxime Samson; Marion Ciudad; Julien Vinit; Catherine Vergely; Denis Caillot; Pascal Foucher; Laurent Lagrost; Salem Chouaib; Emmanuel Katsanis; Nicolas Larmonier; Bernard Bonnotte
Journal:  J Immunol       Date:  2011-07-29       Impact factor: 5.422

5.  Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis.

Authors:  Florina Olaru; Thomas Döbel; Anke S Lonsdorf; Stephanie Oehrl; Michael Maas; Alexander H Enk; Marc Schmitz; Elisabeth F Gröne; Hermann-J Gröne; Knut Schäkel
Journal:  JCI Insight       Date:  2018-06-07

6.  Plasmodium falciparum Infection of Human Volunteers Activates Monocytes and CD16+ Dendritic Cells and Induces Upregulation of CD16 and CD1c Expression.

Authors:  Anne C Teirlinck; Meta Roestenberg; Else M Bijker; Stephen L Hoffman; Robert W Sauerwein; Anja Scholzen
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

7.  Human liver dendritic cells promote T cell hyporesponsiveness.

Authors:  Zubin M Bamboat; Jennifer A Stableford; George Plitas; Bryan M Burt; Hoang M Nguyen; Alexander P Welles; Mithat Gonen; James W Young; Ronald P DeMatteo
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

8.  Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.

Authors:  Marieta Toma; Rebekka Wehner; Anja Kloß; Linda Hübner; Georgia Fodelianaki; Kati Erdmann; Susanne Füssel; Stefan Zastrow; Matthias Meinhardt; Barbara Seliger; Dorothee Brech; Elfriede Noessner; Torsten Tonn; Knut Schäkel; Martin Bornhäuser; Michael P Bachmann; Manfred P Wirth; Gustavo Baretton; Marc Schmitz
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

9.  Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.

Authors:  Lai Sum Leoh; Tracy R Daniels-Wells; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Mol Immunol       Date:  2015-07-29       Impact factor: 4.407

10.  Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis.

Authors:  S Q Ashraf; P Umana; E Mössner; T Ntouroupi; P Brünker; C Schmidt; J L Wilding; N J Mortensen; W F Bodmer
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.